The MBC Annual Meeting
Sheraton Boston Hotel

Register Here!

2008 constitutes a landmark year for Massachusetts life sciences industries with the much anticipated enactment of the $1 Billion Massachusetts Life Science Initiative; momentous times demand momentous events. Be part of the Massachusetts Biotechnology Council's most important event this year, the 2008 MBC Annual Meeting.

Biotechnology leaders will gather to network, compare notes, learn about the latest industry trends, and share in the wisdom and expertise of their esteemed colleagues. Hear industry experts analyze tectonic shifts in healthcare that will impact business, science and policy. Explore featured panel presentations on the landscape for reimbursement of innovative therapeutics, the prospects for personalized medicine, and opportunities sparked by the state's soon-to-be-passed $1 billion Life Sciences Initiative.

Join the MBC and colleagues as we delve into compelling topics during the most momentous era in biotechnology history.

REGISTRATION FEES

MBC Members: $295.00
Non-MBC Members: $595.00
On-site Registrants: Additional $50.00

PROGRAM OVERVIEW

2:30pm - MBC Business Meeting

3:30pm-Breakout Sessions

A Drug Just For Me? What The Future Really Holds In Store For Personalized Medicine

Moderator: Douglas Onsi, Esq., Venture Partner, HealthCare Ventures

Panelists:
     Mara Aspinall, Senior Advisor, Genzyme Corp and Past President, Genzyme Genetics
     Elan Ezickson, Chief Business Officer, AVEO Pharmaceuticals, Inc.
     Mason Freeman, M.D., Clinical Director of Adult Medical Genetics, Massachusetts General Hospital
      Gautam Jaggi, Senior Manager, Ernst & Young Global Biotechnology Center

If You Build It, Will They Pay? The Coming Challenges Of Coverage And Reimbursement In The Innovative Age

Moderator: Bob Flaherty, President & CEO, Athena Diagnostics, Inc.

Panelists:
     Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP
     John Taylor, Executive Vice President for Health, Biotechnology Industry
     Rina Wolf, MHA, Vice President, Reimbursement & Payor Relations, RedPath Integrated Pathology
     Barry Zallen, M.D., Medical Director, Blue Cross Blue Shield of Massachusetts

4:30pm - Closing Plenary

Opportunity Of A Lifetime: How MBC Members Can Benefit From The State's $1 Billion Life Sciences Initiative

Moderator: Peter Abair, Director of Economic Development, Massachusetts Biotechnology Council

      Scot Butcher, Managing Director, Business Incentives Advisory, Duff & Phelps, LLC
      Daniel O'Connell, Secretary, Office of Housing and Economic Development, Commonwealth of Massachusetts
      Michael J. Rodrigues, State Representative, 8th Bristol District of Massachusetts, Commonwealth of Massachusetts (invited)
      Melissa A. Walsh, Chief of Staff, Massachusetts Life Sciences Center
      Jack M. Wilson, Ph.D., President, The University of Massachusetts

5:30pm - Networking Reception

For agenda and detailed information go here.